|
1
|
Howard JM and Sanford JR: The RNAissance
family: SR proteins as multifaceted regulators of gene expression.
Wiley Interdiscip Rev RNA. 6:93–110. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Manley JL and Krainer AR: A rational
nomenclature for serine/arginine-rich protein splicing factors (SR
proteins). Genes Dev. 24:1073–1074. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhou Z and Fu XD: Regulation of splicing
by SR proteins and SR protein-specific kinases. Chromosoma.
122:191–207. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sahebi M, Hanafi MM, van Wijnen AJ, Azizi
P, Abiri R, Ashkani S and Taheri S: Towards understanding pre-mRNA
splicing mechanisms and the role of SR proteins. Gene. 587:107–119.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Twyffels L, Gueydan C and Kruys V:
Shuttling SR proteins: More than splicing factors. FEBS J.
278:3246–3255. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Anczukow O and Krainer AR: Splicing-factor
alterations in cancers. RNA. 22:1285–1301. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shilo A, Siegfried Z and Karni R: The role
of splicing factors in deregulation of alternative splicing during
oncogenesis and tumor progression. Mol Cell Oncol. 2:e9709552014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Das S and Krainer AR: Emerging functions
of SRSF1, splicing factor and oncoprotein, in RNA metabolism and
cancer. Mol Cancer Res. 12:1195–1204. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cavaloc Y, Popielarz M, Fuchs JP, Gattoni
R and Stevenin J: Characterization and cloning of the human
splicing factor 9G8: A novel 35 kDa factor of the serine/arginine
protein family. EMBO. 13:2639–2649. 1994.
|
|
10
|
Popielarz M, Cavaloc Y, Mattei MG, Gattoni
R and Stevenin J: The gene encoding human splicing factor 9G8.
Structure, chromosomal localization, and expression of
alternatively processed transcripts. J Biol Chem. 270:17830–17835.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Galiana-Arnoux D, Lejeune F, Gesnel MC,
Stevenin J, Breathnach R and Del Gatto-Konczak F: The CD44
alternative v9 exon contains a splicing enhancer responsive to the
SR proteins 9G8, ASF/SF2, and SRp20. J Biol Chem. 278:32943–32953.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
ten Dam GB, Zilch CF, Wallace D, Wieringa
B, Beverley PC, Poels LG and Screaton GR: Regulation of alternative
splicing of CD45 by antagonistic effects of SR protein splicing
factors. J Immunol. 164:5287–5295. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Raponi M, Kralovicova J, Copson E, Divina
P, Eccles D, Johnson P, Baralle D and Vorechovsky I: Prediction of
single-nucleotide substitutions that result in exon skipping:
Identification of a splicing silencer in BRCA1 exon 6. Hum Mutat.
32:436–444. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gao L, Wang J, Wang Y and Andreadis A: SR
protein 9G8 modulates splicing of tau exon 10 via its proximal
downstream intron, a clustering region for frontotemporal dementia
mutations. Mol Cell Neurosci. 34:48–58. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huang Y and Steitz JA: Splicing factors
SRp20 and 9G8 promote the nucleocytoplasmic export of mRNA. Mol
Cell. 7:899–905. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Swartz JE, Bor YC, Misawa Y, Rekosh D and
Hammarskjold ML: The shuttling SR protein 9G8 plays a role in
translation of unspliced mRNA containing a constitutive transport
element. J Biol Chem. 282:19844–19853. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hatakeyama S, Sugihara K, Nakayama J,
Akama TO, Wong SM, Kawashima H, Zhang J, Smith DF, Ohyama C, Fukuda
M and Fukuda MN: Identification of mRNA splicing factors as the
endothelial receptor for carbohydrate-dependent lung colonization
of cancer cells. Proc Natl Acad Sci USA. 106:pp. 3095–3100. 2009;
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kim HR, Lee GO, Choi KH, Kim DK, Ryu JS,
Hwang KE, Na KJ, Choi C, Kuh JH, Chung MJ, et al: SRSF5: A novel
marker for small-cell lung cancer and pleural metastatic cancer.
Lung Cancer. 99:57–65. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bouillet P and O'Reilly LA: CD95, BIM and
T cell homeostasis. Nat Rev Immunol. 9:514–519. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Villa-Morales M and Fernandez-Piqueras J:
Targeting the Fas/FasL signaling pathway in cancer therapy. Exp
Opin Ther Targets. 16:85–101. 2012. View Article : Google Scholar
|
|
21
|
David CJ and Manley JL: Alternative
pre-mRNA splicing regulation in cancer: Pathways and programs
unhinged. Genes Dev. 24:2343–2364. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cheng J, Zhou T, Liu C, Shapiro JP, Brauer
MJ, Kiefer MC, Barr PJ and Mountz JD: Protection from Fas-mediated
apoptosis by a soluble form of the Fas molecule. Science.
263:1759–1762. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kondera-Anasz Z, Mielczarek-Palacz A and
Sikora J: Soluble Fas receptor and soluble Fas ligand in the serum
of women with uterine tumors. Apoptosis. 10:1143–1149. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sheen-Chen SM, Chen HS, Eng HL and Chen
WJ: Circulating soluble Fas in patients with breast cancer. World J
Surg. 27:10–13. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu JH, Wei S, Lamy T, Li Y,
Epling-Burnette PK, Djeu JY and Loughran TP Jr: Blockade of
Fas-dependent apoptosis by soluble Fas in LGL leukemia. Blood.
100:1449–1453. 2002.PubMed/NCBI
|
|
26
|
Tejedor JR, Papasaikas P and Valcarcel J:
Genome-wide identification of Fas/CD95 alternative splicing
regulators reveals links with iron homeostasis. Mol Cell. 57:23–38.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fu Y, Huang B, Shi Z, Han J, Wang Y,
Huangfu J and Wu W: SRSF1 and SRSF9 RNA binding proteins promote
Wnt signalling-mediated tumorigenesis by enhancing beta-catenin
biosynthesis. EMBO Mol Med. 5:737–750. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Saijo S, Kuwano Y, Masuda K, Nishikawa T,
Rokutan K and Nishida K: Serine/arginine-rich splicing factor 7
regulates p21-dependent growth arrest in colon cancer cells. J Med
Invest. 63:219–226. 2016. View Article : Google Scholar : PubMed/NCBI
|
